Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunic Inc (NQ: IMUX )

1.160 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,035
Open 1.160
Bid (Size) 1.160 (1)
Ask (Size) 1.190 (1)
Prev. Close 1.160
Today's Range 1.160 - 1.160
52wk Range 0.9451 - 3.170
Shares Outstanding 26,249,439
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immunic: Q3 Earnings Insights
Via Benzinga
A Preview Of Immunic's Earnings
Via Benzinga

Performance

YTD
-17.14%
-17.14%
1 Month
-1.69%
-1.69%
3 Month
-27.50%
-27.50%
6 Month
-30.95%
-30.95%
1 Year
-6.45%
-6.45%

More News

Read More
Immunic CSO hails "great" progress with MS program
Via News Direct
Immunic CSO hails "great" progress with MS program
Via TheNewswire.com
Immunic "super excited" about latest PMS trial data
Via News Direct
Immunic "super excited" about latest PMS trial data
Via TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
Via News Direct
Immunic Inc set to bring relief with encouraging results
Via News Direct
Immunic Inc set to bring relief with encouraging results
Via TheNewswire.com
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate
Via Benzinga
Recap: Immunic Q1 Earnings
Via Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
Via News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
Via TheNewswire.com
Immunic CEO says Q2 results "couldn't be better"
Via News Direct
Immunic CEO says Q2 results "couldn't be better"
Via TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
Via TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Via News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Via TheNewswire.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.